ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,198Medicare Part D Prescriptions Filled, Including Refills

Rank: 50 out of 1300

$425K Total Retail Price of All Prescriptions

Rank: 56 out of 1300

315 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 315 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

16% of this provider’s 315 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 7,504 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
LEVOTHYROXINE SODIUM 466 441 1 1
FUROSEMIDE 403 376 2 8
POTASSIUM CHLORIDE 332 314 3 18
LISINOPRIL 296 268 4 2
WARFARIN SODIUM 267 232 5 9
CITALOPRAM HBR 246 226 6 19
SIMVASTATIN 240 234 7 3
METOPROLOL TARTRATE 167 162 8 11
AMLODIPINE BESYLATE 165 161 9 6
HYDROCODONE-ACETAMINOPHEN 159 139 S3 10 5
OMEPRAZOLE 154 150 11 4
HYDROCHLOROTHIAZIDE 132 132 12 10
TRAMADOL HCL 124 120 13 17
GABAPENTIN 114 101 14 15
METFORMIN HCL 113 110 15 7
DOXAZOSIN MESYLATE 101 101 16 71
ATENOLOL 94 89 17 12
LOSARTAN POTASSIUM 93 90 18 16
FAMOTIDINE 89 86 19 73
OXYCODONE-ACETAMINOPHEN 88 87 S2 20 28
METOPROLOL SUCCINATE 84 81 21 24
NAMENDA 80 80 22 51
CARVEDILOL 80 75 22 38
CALCITONIN-SALMON 80 80 22 286
ALBUTEROL SULFATE 75 74 25 162
SPIRONOLACTONE 72 67 26 55
DETROL LA 72 68 26 189
DONEPEZIL HCL 71 71 28 32
FINASTERIDE 70 70 29 80
FLUOXETINE HCL 67 52 30 31
ALLOPURINOL 64 64 31 29
ATORVASTATIN CALCIUM 64 51 31 13
FENTANYL 59 58 S2 33 56
LANTUS 55 55 34 43
ADVAIR DISKUS 55 51 34 41
POLYETHYLENE GLYCOL 3350 55 53 34 65
DIGOXIN 55 55 34 48
SERTRALINE HCL 54 36 38 26
ZOLPIDEM TARTRATE 54 54 38 14
TAMSULOSIN HCL 53 49 40 25
SPIRIVA 52 46 41 45
ENALAPRIL MALEATE 52 52 41 93
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 10, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.